Transfusion · 2026
Intra-apheresis CD34+ cell count: A dynamic approach to predicting peripheral blood stem cell collection yield.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Alswied Abdullah, Song Linda, Thioye-Sall Mame, Chen Leonard N, West-Mitchell Kamille, Zhang Nan, Jin Ping, Stroncek David, Dinh Anh
Аннотация
BACKGROUND: Accurate prediction of peripheral blood stem cell (PBSC) yield is essential for optimizing hematopoietic stem cell collections. Traditional CD34+ prediction formulas often overlook the ongoing recruitment of CD34+ cells during the collection procedure. This study evaluated whether a single intra-apheresis CD34+ measurement could improve yield prediction compared to existing prediction models.
METHODS: We retrospectively analyzed 150 PBSC collections from 123 autologous and allogenic donors. A single intraprocedural CD34+ measurement and final collection yield were obtained, and univariable and multivariable linear regressions were developed to assess predictive accuracy. Model stability and generalizability were tested via bootstrap resampling and cross-validation. Subgroup analyses by age, sex, weight, diagnosis, and sampling time were performed to confirm robustness. We also compared our results against published pre-apheresis formulas.
RESULTS: Intra-apheresis CD34+ counts showed a strong correlation with the final yield (r = 0.97; R2 = 0.95). Subgroup analyses across donor demographics and clinical factors yielded similarly high R2 values (0.91-0.99). Multivariable analysis identified intra-apheresis CD34+ measurement as the primary contributor (β = 0.67, p <.0001). Later sampling (≥1.20 of total blood volumes processed) reduced error metrics relative to earlier draws. Compared to pre-apheresis models, the intra-apheresis approach achieved higher R2 and lower error metrics.
DISCUSSION: A single intra-apheresis CD34+ measurement, particularly at or beyond 1.20 processed blood volumes, offers a reliable, real-time predictor of final PBSC yield. This intraprocedural approach outperforms published pre-apheresis formulas, enabling more efficient collection and reduced donor burden across diverse clinical scenarios.
METHODS: We retrospectively analyzed 150 PBSC collections from 123 autologous and allogenic donors. A single intraprocedural CD34+ measurement and final collection yield were obtained, and univariable and multivariable linear regressions were developed to assess predictive accuracy. Model stability and generalizability were tested via bootstrap resampling and cross-validation. Subgroup analyses by age, sex, weight, diagnosis, and sampling time were performed to confirm robustness. We also compared our results against published pre-apheresis formulas.
RESULTS: Intra-apheresis CD34+ counts showed a strong correlation with the final yield (r = 0.97; R2 = 0.95). Subgroup analyses across donor demographics and clinical factors yielded similarly high R2 values (0.91-0.99). Multivariable analysis identified intra-apheresis CD34+ measurement as the primary contributor (β = 0.67, p <.0001). Later sampling (≥1.20 of total blood volumes processed) reduced error metrics relative to earlier draws. Compared to pre-apheresis models, the intra-apheresis approach achieved higher R2 and lower error metrics.
DISCUSSION: A single intra-apheresis CD34+ measurement, particularly at or beyond 1.20 processed blood volumes, offers a reliable, real-time predictor of final PBSC yield. This intraprocedural approach outperforms published pre-apheresis formulas, enabling more efficient collection and reduced donor burden across diverse clinical scenarios.